Takeda Pharmaceutical (TAK) Operating Margin (2017 - 2025)
Historic Operating Margin for Takeda Pharmaceutical (TAK) over the last 9 years, with Q4 2025 value amounting to 14.17%.
- Takeda Pharmaceutical's Operating Margin fell 38300.0% to 14.17% in Q4 2025 from the same period last year, while for Dec 2025 it was 26.74%, marking a year-over-year increase of 69500.0%. This contributed to the annual value of 7.48% for FY2025, which is 24600.0% up from last year.
- As of Q4 2025, Takeda Pharmaceutical's Operating Margin stood at 14.17%, which was down 38300.0% from 28.52% recorded in Q3 2025.
- In the past 5 years, Takeda Pharmaceutical's Operating Margin ranged from a high of 31.65% in Q1 2025 and a low of 0.96% during Q1 2024
- In the last 5 years, Takeda Pharmaceutical's Operating Margin had a median value of 16.96% in 2023 and averaged 19.06%.
- Per our database at Business Quant, Takeda Pharmaceutical's Operating Margin tumbled by -168800bps in 2024 and then skyrocketed by 326100bps in 2025.
- Quarter analysis of 5 years shows Takeda Pharmaceutical's Operating Margin stood at 12.92% in 2021, then grew by 4bps to 13.4% in 2022, then surged by 66bps to 22.24% in 2023, then dropped by -19bps to 18.0% in 2024, then decreased by -21bps to 14.17% in 2025.
- Its last three reported values are 14.17% in Q4 2025, 28.52% for Q3 2025, and 28.72% during Q2 2025.